| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/15/2009 | CN101406577A Chinese medicine for treating urethral calculus |
| 04/15/2009 | CN101406575A Integrated Chinese and western medicine for treating urinary stone |
| 04/15/2009 | CN101406556A Chinese medicine preparation for treating acute prostatitis, prostatic hyperplasia and preparation method thereof |
| 04/15/2009 | CN101406535A Chinese medicinal decoction for treating urinary lithiasis |
| 04/15/2009 | CN101406496A Prescription for treating prostatitis and other reproductive system diseases of male |
| 04/15/2009 | CN101406492A Compound Cordyceps sinensis oil soft capsule and preparation technique |
| 04/15/2009 | CN101406464A Treatment or prevention of urogenital atrophy and its symptoms in women |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/15/2009 | CN100477995C Fortifier |
| 04/15/2009 | CN100477990C Tanshinoue dropping pills and preparing method |
| 04/15/2009 | CN100477988C Use of pogostemonis alkane type sesquiterpene compound as vegetative female sex normone |
| 04/14/2009 | US7517996 methyl 3-(4-{4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-isoxazolyl}-benzylsulfanyl)propionate; compounds inhibit the physiological activity of lysophosphatidic acid (LPA); treatment of fibrosis of organs (liver, kidney, lung, and the like), hepatic disease |
| 04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
| 04/14/2009 | US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 04/14/2009 | US7517888 A1 adenosine receptor antagonists |
| 04/14/2009 | US7517686 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 04/14/2009 | CA2417050C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2371789C Novel guanidine derivatives as inhibitors of cell adhesion |
| 04/14/2009 | CA2359440C Phenylphenanthridines with pde-iv inhibiting activity |
| 04/14/2009 | CA2337797C Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 04/14/2009 | CA2192941C Sterol derivatives used for regulation of meiosis |
| 04/09/2009 | WO2009045503A1 Method of treating polycystic kidney diseases with ceramide derivatives |
| 04/09/2009 | WO2009044930A1 Pharmaceutical composition for inhibiting the accumulation of amyloid-β protein |
| 04/09/2009 | WO2009044899A1 Nucleic acid capable of regulating the proliferation of cell |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044006A2 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid the pharmaceutically-acceptable esters and salts and solvates thereof for use as medicament |
| 04/09/2009 | WO2009005551A3 Transcription factor modulating compounds and methods of use thereof |
| 04/09/2009 | WO2008149163A3 Potassium ion channel modulators and uses thereof |
| 04/09/2009 | WO2008122667A3 Ureylene derivatives |
| 04/09/2009 | US20090093529 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093433 SENSE mRNA THERAPY |
| 04/09/2009 | US20090093402 Albumin Fusion Proteins |
| 04/09/2009 | US20090092611 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092605 Compositions and methods for the treatment of immune related diseases |
| 04/09/2009 | US20090092545 Antibodies that bind both bcma and taci |
| 04/09/2009 | CA2701649A1 Method of treating polycystic kidney diseases with ceramide derivatives |
| 04/09/2009 | CA2701618A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 04/09/2009 | CA2701435A1 Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
| 04/09/2009 | CA2701406A1 Benzoxazinone derivative |
| 04/08/2009 | EP2045245A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 04/08/2009 | EP2044946A1 Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
| 04/08/2009 | CN101405005A Methods for modulating bladder function |
| 04/08/2009 | CN101401894A Compound formulation for medicament for diuresis and expelling stone |
| 04/08/2009 | CN101401830A Preparation method for extracting flavone from purslane and uses thereof |
| 04/08/2009 | CN101401817A Preparation for pharmaceutical chemicals for solubilizing uropoiesis stone |
| 04/08/2009 | CN101401639A Kidney tonifying health wine and method of preparing the same |
| 04/08/2009 | CN100475939C A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement and an animal feed product |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475816C Reverse-turn mimetics and method relating thereto |
| 04/08/2009 | CN100475775C Highly pure bases of 3,3-diphenyl propylamine monoesters |
| 04/08/2009 | CN100475267C Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycin |
| 04/08/2009 | CN100475242C Chinese medicinal preparation for treating respiration system virus infection disease and preparation method thereof |
| 04/08/2009 | CN100475241C Yankening medicine preparation and preparing method thereof |
| 04/08/2009 | CN100475207C 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 04/07/2009 | US7514571 Bicyclo derivative |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514449 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 04/07/2009 | US7514422 To treat obesity, schizophrenia, anxiety, depression, alcoholism; using 3-benoazepine compounds like 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin); serotonin 2c receptor agonists |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | CA2493633C Kinase inhibitors |
| 04/07/2009 | CA2415890C N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/07/2009 | CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/07/2009 | CA2376033C Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/07/2009 | CA2339253C Inhibitors of p38 |
| 04/02/2009 | WO2009041714A1 External preparation for free radical diseases |
| 04/02/2009 | WO2009041521A1 Quinolone derivative |
| 04/02/2009 | WO2009040671A1 Novel therapeutic uses of adrenergic alpha-1 receptor antagonists |
| 04/02/2009 | WO2009040388A1 Controlled release tamsulosin hydrochloride tablets and a process of making them |
| 04/02/2009 | US20090088457 Primary Amines as Renin Inhibitors |
| 04/02/2009 | US20090088426 (3S,4R,5R)-3-hydroxymethyl-4-[4-((S)-3-methoxy-2-methyl-propoxymethyl)-phenyl]-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo [1,4]oxazin-6-ylmethoxy]-piperidine-1-carboxylic acid benzyl ester; improvement of the pharmacokinetic properties; better bioavailability |
| 04/02/2009 | US20090088389 Novel x-conotoxin peptides (-ii) |
| 04/02/2009 | CA2700591A1 Controlled release tamsulosin hydrochloride tablets and a process of making them |
| 04/02/2009 | CA2700088A1 Quinolone derivative |
| 04/01/2009 | EP2042591A1 Erythropoietin-producing organoid precursor, method of constructing the same and method of treating erythropoietin-related disease |
| 04/01/2009 | EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA) |
| 04/01/2009 | EP2042184A1 Physiologically active polypeptide, polymer micelle having protein enclosed therein, and process for production of the polymer micelle |
| 04/01/2009 | EP2042179A1 Novel therapeutic uses of adrenergic alpha-1 receptor antagonists |
| 04/01/2009 | EP2042169A1 Controlled release tamsulosin hydrochloride tablets and a process of making them |
| 04/01/2009 | EP2041127A2 Indole compounds |
| 04/01/2009 | EP2041094A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 04/01/2009 | EP2041086A1 Indole compounds |
| 04/01/2009 | EP2040750A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators |
| 04/01/2009 | EP1473295B1 Fused bicyclic pyrimidine derivatives |
| 04/01/2009 | EP1137666B9 Glp-1 analogues |
| 04/01/2009 | CN101400672A Pyrazolylquinazolinones as potassium channel openers |
| 04/01/2009 | CN101397315A Tonka bean camphor glycosides compounds, preparation method thereof and medicament composition and use thereof |
| 04/01/2009 | CN101397296A Levalfuzosin, preparation method and use thereof |
| 04/01/2009 | CN101396520A Preparation method of spleen-invigorating and kidney-strengthening traditional Chinese medicine |
| 04/01/2009 | CN101396506A Traditional Chinese medicine for treating chronic glomerulonephritis |
| 04/01/2009 | CN101396493A Medicine formulation for treating lithiasis |
| 04/01/2009 | CN101396469A Traditional Chinese medicine for treating diabetic nephrosis |
| 04/01/2009 | CN101396439A Manufacture method of powder capable of quickly removing five gornorrheas |
| 04/01/2009 | CN100473400C Bio-fermentation technique for composite vegetable drug and vegetable fermented drug for treating nephritis |
| 04/01/2009 | CN100473391C Novel use of Cynoglossum |